A recent study suggests that individuals who come off popular slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who end conventional lifestyle plans.
Published data in a major medical journal shows that while overweight people can lose substantial amounts of their body weight while on the medication, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users purchasing such treatments need to be cognizant of the danger of quick weight regain when the medication ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to original mass in about one and a half years.
Analyzing Therapies
The study, which reviewed dozens of trials involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.
The team emphasize that individuals who shed pounds through diet and exercise typically experience a more gradual creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Rapid Regain
Nutrition scientists suggest the way of the drugs explains the amplified regain.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' results in appetite is uncontrolled, making overeating much more probable."
A Chronic Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
A number of clinicians contend that, given the likelihood of weight regain, the treatment should be considered life-long.
This opinion is echoed by drug manufacturers, who state that the results "highlight the long-term character of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
Users who have stopped the medication report a intense resurgence of appetite.
"I experienced a switch activating and you're instantly ravenous," said an individual.
This challenge is exacerbated if users have not adopted sustainable lifestyle or habit changes during therapy.
Growing Use
Recent estimates indicate that a significant number of people in the UK have tried these injections in the past year, with demand being substantial.
- Adoption is higher among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Ultimately, experts stress that while these medications are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on integrated lifestyle management.
